Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts

Acta Pharmacologica Sinica

Volumn 31, Issue 5, 2010, Pages 554-559

  Chen, Li Jun ^a   Li, Wan De ^b   Li, Shi Feng ^a   Su, Xing Wen ^a   Lin, Guang Yun ^a   Huang, Yi Jun ^a   Yan, Guang Mei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bleomycin; Copper; Human fetal lung fibroblast; Lysyl oxidase; Pulmonary fibrosis

Indexed keywords

3 AMINOPROPIONITRILE; BLEOMYCIN; COPPER; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CATALYSIS; CELL CULTURE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; WESTERN BLOTTING;

AMINOPROPIONITRILE; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CELL LINE; COPPER; FETUS; FIBROBLASTS; HUMANS; LUNG; PROTEIN-LYSINE 6-OXIDASE; PULMONARY FIBROSIS; UP-REGULATION;

EID: 77952064405     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.44     Document Type: Article

References (44)

1. Cross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-25.
2. Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, et al. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA 2000;15:1778-83.
3. Khalil N, O'Connor R. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ 2004;171:153-60.
4. Verma S, Slutsky AS. Idiopathic pulmonary fibrosis - new insights. N Engl J Med 2007;356:1370-2.
5. Travis WD, King TE, Bateman ED Jr, Lynch DA. American Thoracic Society/European respiratory Society International Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
6. Zhang K, Phan SH. Cytokines and pulmonary fibrosis. Biol Signals 1996;5:232-9.
7. Vaillant P, Menard O, Vignaud JM, Martinet N, Martinet Y. The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 1996;51:145-52.
8. Bringardner BD, Baran CP, Eubank TD, Marsh CB. The role of Inflamma tion in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008;10:287-301.
9. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51.
10. Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29: S93-7. (Pubitemid 37070317)
11. Kagan HM. Characterization and regulation of lysyl oxidase. In Mecham, P R (Ed), Biology of the Extracellular Matrix, Vol I: Regulation of matrix accumulation. Academic Press, Orlando, FL. 1986 p 321-98.
12. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, et al. Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-β1 and prostaglandin E2. Am J Respir Cell Mol Biol 1994;11:751-5.
13. Counts DF, Evans JN, Dipetrillo TA, Sterling KM Jr, Kelley J. Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J Pharmacol Exp Ther 1981;219:675-8.
14. Siegel RC, Chen KH, Greenspan JS, Aguiar JM. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat. Proc Natl Acad Sci USA 1978;75:2945-9.
15. Kagan HM. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Path Res Pract 1994;90:910-9.
16. Kagan HM, Li W. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. J Cell Biochemistry 2003;88:660-72.
17. Chou DK, Zhao Y, Gao S, Chou IN, Toselli P, Stone P, et al. Pertubation of copper (Cu) homeostasis and expression of Cu-binding proteins in Cadmium-resistant lung fibroblasts. Toxicol Sci 2007;99:267-76.
18. Palamakumbura AH, Trackman PC. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 2002;300:245-51.
19. Rogliani P, Mura M, Assunta Porretta M, Saltini C. New perspectives in the treatment of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2008;2:75-93.
20. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001;99:308-19.
21. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway infammation and fibrosis. Proc Am Thorac Soc 2006;3:413-7.
22. Olman MA, Matthay MA. Transforming growth factor-beta induces fibrosis in immune cell-depleted lungs. Am J Physiol Lung Cell Mol Physiol 2003;285: L522-6.
23. Gauldie J, Sime PJ, Xing Z, Marr B, Tremblay GM. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr Top Pathol 1999;93:35-45.
24. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
25. Gharaee-Kermani M, Hu B, Phan SH, Gyetko MR. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr Med Chem 2009;16:1400-17.
26. Atamas SP, White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine growth Factor Rev 2003;14:537-50.
27. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998;11:1218-21.
28. Trojanowska M. Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 2008;47: suppl 5: v2-4.
29. Marinelli WA, Polunovsky VA, Harmon KR, Bitterman PB. Role of platelet-derived growth factor in pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5:503-4.
30. Inoue Y, King TE, Barker e Jr, Daniloff E, Newman LS. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002;166:765-73.
31. Sannes PL, Khosla J, Johnson S, Goralska M, McGahan C, Menard M. Basic fibroblast growth factor in fibrosing alveolitis induced by oxygen stress. Chest 1996;109:44s-45s.
32. Henke C, Marineili W, Jessurun J, Fox J, Harms D, Peterson M, et al. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol 1993;143:1189-99.
33. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008;32:1068-81.
34. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990;344:245-7.
35. Krein PM, Winston BW. Roles for insulin-like growth factor 1 and transforming growth factor-beta in fibrotic lung disease. Chest 2002;122:289s-93s.
36. Bouros D, Antoniou KM, Tzouvelekis A, Siafakas NM. Interferongamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther 2006;6:1051-60.
37. Hoyle GW, Brody AR. IL-9 and lung fibrosis: a Th2 good guy? Am J Respir Cell Mol Biol 2001;24:365-7.
38. Martinet Y, Menard O, Vaillant P, Vignaud JM, Martinet N. Cytokines in human lung fibrosis. Arch Toxicol Supp 1996;18:127-39.
39. Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol 1998;16:387-98.
40. Rucker RB, Romero-Chapman N, Wong T, Lee J, Steinberg FM, McGee C, et al. Modulation of lysyl xoidase by dietary copper in rats. J Nutr 1996;126:51-60.
41. Zhao Y, Gao S, Chou I.-N., Toselli P, Stone P, Li W. Inhibition of the expres sion of lysyl oxidase and its substrates in cadmium-resistant rat fetal lung fibroblasts. Toxicol Sci 2006;90:478-89.
42. Hardman JG, Limbird LE. Goodman & Gilman's the Pharmacological Basis of Therapeutics (11th edition). New York: McGraw-Hill Companies, 2006.
43. Mattie MD, Freedman JH. Copper-inducible transcription: Regulation by metal-and oxidative stress responsive pathways. Am J Physio Cell Physio 2004;286: C293-C301.
44. Gao S, Zhao Y, Kong L, Toselli P, Chou IN, Stone P, et al. Cloning and characterization of the rat lysyl oxidase gene promoter: Identification of core promoter elements and functional nuclear factor I binding sites. J Bio Chem 2007;282:25322-37.